Prospects of fibrinolytic proteases of bacteria from sea cucumber fermentation products as antithrombotic agent [PDF]
BIO Web of Conferences, 2020 Cardiovascular disease is among the largest contributors of premature mortality in the world caused by inflammation of blood vessels. The abnormalities provoke thrombus formation or thrombosis blocking blood vessels leading to strokes, heart attacks and ...
Fuad Hayatun +9 more
doaj +2 more sources
Anti-fibrinolytic agents in post partum haemorrhage: a systematic review [PDF]
BMC Pregnancy and Childbirth, 2009 Background Post partum haemorrhage is a leading cause of maternal death worldwide. It also contributes to maternal morbidity as women may require a hysterectomy to control bleeding, or may require a blood transfusion, which can transmit viral infections.
Blackhall Karen +4 more
doaj +2 more sources
Türk Kardiyoloji Derneği Arşivi, 2020 Objective: Myocardial infarction is a leading cause of morbidity and mortality. Fibrinolytic administration is still a life-saving choice in ST-segment elevated myocardial infarction (STEMI), but the rate of successful reperfusion can be inconsistent ...
Ali Çoner +4 more
doaj +2 more sources
Indonesian Journal of Medical Laboratory Science and TechnologyThrombotic disorders are one of the leading causes of death in cardiovascular patients and contribute to the incidence of non-infectious diseases. The search for new anticoagulant agents to overcome the limitations associated with existing anticoagulant
Muhammad Ardi Afriansyah +2 more
doaj +3 more sources
Novel Treatment of Staphylococcus aureus Device-Related Infections Using Fibrinolytic Agents. [PDF]
Antimicrob Agents Chemother, 2018 Hogan S, O'Gara JP, O'Neill E.
europepmc +3 more sources
Myocardial rupture after percutaneous coronary intervention of an unstable RCA lesion in myocardial infarction and concomitant stroke treated with intravenous fibrinolytic agents: A case report. [PDF]
Clin Case Rep, 2021 Bay B +4 more
europepmc +2 more sources
Perspective and update: intrapleural fibrinolytic therapy for pleural infections and other forms of pleural organization [PDF]
Respiratory ResearchIntrapleural fibrinolytic therapy (IPFT), also known as intrapleural enzymatic therapy (IET), has been utilized for decades to treat pleural infections by expediting drainage in patients with pleural organization.
Torry A. Tucker +2 more
doaj +2 more sources
Enhanced Production of Fibrinolytic Enzyme from Pseudomonas aeruginosa by Optimization Media Components [PDF]
Journal of Applied Sciences and Nanotechnology, 2021 Fibrinolytic enzyme is factor that lysis fibrin clots. This fibrinolytic factor has prospective use to treat cardiovascular diseases, such as stroke and heart attack. Cardiovascular diseases attracted worldwide attention for their elevation morbidity and
Bilal Jasim, Entesar Ali
doaj +1 more source
Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells. [PDF]
, 2012 Mesothelial cells are critical in the pathogenesis of post-surgical intraabdominal adhesions as well as in the deterioration of the peritoneal membrane associated with long-term peritoneal dialysis.
Djafarzadeh, Roghieh +10 more
core +14 more sources
Marine Drugs, 2022 Cardiovascular diseases (CVDs) have emerged as a major threat to global health resulting in a decrease in life expectancy with respect to humans. Thrombosis is one of the foremost causes of CVDs, and it is characterized by the unwanted formation of ...
Noora Barzkar +2 more
doaj +1 more source